HOME >> BIOLOGY >> NEWS
Engineered Neo-Organs For Bladder Replacement

In this research, the investigators created a new form of bladder in vitro, outside the living organism in the lab, and implanted it in 6 beagle dogs. For this study, a total of 14 beagles had a cystectomy. Two dogs underwent closure without a reconstructive procedure. Six beagles had bladder reconstruction with a cell-free biodegradable polymer. The third group of six dogs received reconstruction using a bladder-shaped biodegradable polymer that delivered autologous cells from the bladder epithelium, plus smooth muscle cells. The cells had been expanded separately from a previously harvested autologous bladder biopsy. The researchers performed preoperative and postoperative urinary flow and X-ray studies. After their initial operation and recovery, the animals were sacrificed at 1,2,3,4,6 and 11 months. The investigators performed gross pathology, along with histological and other analyses. Their results showed that in the tissue engineered replacement bladders, the average bladder capacity was 95% of the original pre- cystectomy volume. The polymer-only grafts were 46% of preoperative values, and the cystectomy-only controls were at 22%. The compliance of the tissue-engineered bladders (the quality of yielding to fluid pressure) showed almost no difference from pre-operative values. In their analysis, the investigators found that the retrieved tissue engineered bladders had normal cellular organization, consisting of a tri-layer of normal bladder epithelium, submucosa, and muscle. The investigators believe that tissue engineering can create functionally and anatomically normal bladders. They assert that this technology in the future could improve or even supplant conventional methods of bladder replacement or augmentation.


'"/>

Contact: Bill Glitz
wglitz@aol.com
703-532-3797
American Urological Association
31-May-1998


Page: 1

Related biology news :

1. Engineered virus provides impetus in search for HIV vaccine
2. Engineered proteins will lead to synthetic biology
3. Engineered mice point to new target for pain relief
4. Engineered Corn Can Kill Monarch Butterflies
5. Engineered Bacteria Scavenge Heavy Metals
6. Genetically Engineered Mice Exhibit Anxiety, Offering Insight Into Role Of Serotonin In Brain
7. Genetically Engineered Mice Show Characteristic Signs Of Alzheimers, Could Be Ideal Tool For Testing New Therapies
8. Body Building: Tissue Engineered Organs A Heartbeat Away
9. Jefferson Researchers First To Create Genetically Engineered Mouse To Study Photoaging
10. Two-Pronged Attack On Immune System Cells Engineered By HIV Gene vpr: Effects Markedly Reversed By Antisteroid Compound RU-486
11. Three-Way Gene-Gene-Environmental Exposure Interaction Shown By NIEHS To Escalate Smoking-Related Bladder Cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2017)...  Wake Forest Baptist Medical Center today announced Julie Ann ... officer (CEO). Freischlag joins the medical center on May ... M.D., who last year announced that he would transition ... leading it since 2008.   As CEO, ... Baptist,s academic health system, which includes Wake Forest School ...
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/9/2017)... The biomass boiler market report by Transparency Market Research ... in terms of revenue (US$ Mn) based on the ... boilers has been segmented on the basis of feedstock ... based on feedstock type, has been segmented into woody ... urban residues, and others. On the basis of product ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017 According to a ... and derivatives market is fragmented due to the presence of a large ... Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each other ... companies, collectively, held more than 76% of this market in 2016.  ... As of now, ...
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... 2017  Ascendis Pharma A/S (Nasdaq: ASND), a ... to address significant unmet medical needs in rare ... year ended December 31, 2016. ... as we broadened our pipeline and pursued our ... company with an initial focus on endocrinology," said ...
Breaking Biology Technology:
Cached News: